The latest oncology news listed by date, covering all clinical focus areas, tumour types and more
SABCS 2021: Breast cancer patients with oestrogen receptor mutations may benefit from early switch to fulvestrant/palbociclib
Among patients with hormone receptor-positive breast cancer treated with an aromatase inhibitor plus palbociclib (Ibrance),…